First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shares were up 0% during trading on Friday . The company traded as high as GBX 1,629.64 ($20.51) and last traded at GBX 1,626.79 ($20.47). Approximately 8 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 1,655 shares. The stock had previously closed at GBX 1,626 ($20.46).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.0 %
The stock has a market capitalization of £4.81 billion and a price-to-earnings ratio of -1,478.90. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.42 and a quick ratio of 9.27. The business has a fifty day moving average of GBX 1,639.67 and a 200 day moving average of GBX 1,575.53.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What is the S&P/TSX Index?
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- 3 Tickers Leading a Meme Stock Revival
- These 3 Quirky ETFs May Be Strong Plays in 2025
- What Are Treasury Bonds?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
